AzTrials
AzTrials

LanguagesNCT03148470

Impact of Theta Burst Stimulation Over the Left DLPFC on Language Switching

A study testing intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS) in people with Languages, run by Jean-Marie Annoni at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate whether theta burst stimulation (TBS) over the left dorsolateral prefrontal cortex (DLPFC) influences language switching and cognitive flexibility. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Languages
What is being tested?
intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS)
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
41 participants
Where
1 siteSwitzerland
Study dates
Sep 2016to Jul 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • L1 (Swiss)German, knowledge of English as a foreign language
  • 18-45 years of age
  • right-handedness

Who cannot join

  • epilepsy / family history of epilepsy
  • brain surgery, traumatic brain injuries
  • cardiac pacemaker, metallic objects in the head
  • history of neurological diseases or severe psychiatric disorders
  • drug use (alcohol, psychoactive medication)
  • strong headache
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Laboratory for Cognitive and Neurological Sciences

    Fribourg, 1700

Other trials in Switzerland

About this study

Official title: Impact of Theta Burst Stimulation Over the Left Dorsolateral Prefrontal Cortex on Language Switching and Cognitive Flexibility

The purpose of this study is to investigate whether theta burst stimulation (TBS) over the left dorsolateral prefrontal cortex (DLPFC) influences language switching and cognitive flexibility. The experimental paradigm will assess the impact of inhibitory and excitatory prefrontal stimulation by TBS versus sham-TBS over the DLPFC in healthy bilinguals.

Read the detailed description

Background:

Clinical observations and neuroimaging studies seem to confirm the role of executive functions and frontal structures in language processing in bilingual subjects.

Repetitive transcranial magnetic stimulation, such as for example theta burst stimulation (TBS), is increasingly being used as a valuable tool for neuroscientists investigating the underlying mechanisms of cognitive functions. Case studies have shown a change in language switching after bilingual patients received repetitive magnetic stimulation to the left DLPFC. However, there is no study investigating the effect of TBS applied to the DLPFC on language switching in healthy participants.

Procedure:

A planned total of 40 unbalanced bilingual participants will be included. Half of the participants will receive inhibitory theta burst stimulation (continuous TBS), the other half excitatory theta burst stimulation (intermittent TBS). After TBS, different language and nonverbal tasks will be performed while an EEG is measured. Before being stimulated, each subject will conduct the same tasks with a sham-TBS as a baseline measure.

Conditions
Languages
Being tested
Sham iTBS, Sham cTBS, intermittent theta burst stimulation (iTBS), continuous theta burst stimulation (cTBS)
Keywords
theta burst stimulation, Language switching, dorsolateral prefrontal cortex
Medical subject headings
Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sham iTBSDevice

    Placebo stimulation for the iTBS group

  • Sham cTBSDevice

    Placebo stimulation for the cTBS group

  • intermittent theta burst stimulation (iTBS)Device

    Excitatory theta burst stimulation

  • continuous theta burst stimulation (cTBS)Device

    inhibitory theta burst stimulation

Study groups in NCT03148470
Study groupRoleWhat they receive
intermittent theta burst stimulationExperimentalintermittent theta burst stimulation (iTBS) + Sham iTBS
Receives: Device: Sham iTBS; Device: intermittent theta burst stimulation (iTBS)
continuous theta burst stimulationExperimentalcontinuous theta burst stimulation (cTBS) + Sham cTBS
Receives: Device: Sham cTBS; Device: continuous theta burst stimulation (cTBS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching)

    Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (> age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language.

    Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.

    Measured: Within 30 minutes after intervention

Secondary outcomes (1)
  1. Nonverbal Switching

    Nonverbal Switching: response times

    Measured: Within 30 minutes after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2017
  2. Study startSep 2016
  3. Primary completionJul 2018
  4. Study completionJul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03148470
Sponsor's protocol ID
SNF325130_156937_4
Status last verified
Apr 2020
First submitted
1 May 2017
Last updated
22 Apr 2020
Data monitoring committee
No
Individual data sharing
No

Publications

  • Holtzheimer P, Fawaz W, Wilson C, Avery D. Repetitive transcranial magnetic stimulation may induce language switching in bilingual patients. Brain Lang. 2005 Sep;94(3):274-7. doi: 10.1016/j.bandl.2005.01.003.

    PubMed 16098377
  • Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5.

    PubMed 25034472
  • Nardone R, De Blasi P, Bergmann J, Caleri F, Tezzon F, Ladurner G, Golaszewski S, Trinka E. Theta burst stimulation of dorsolateral prefrontal cortex modulates pathological language switching: A case report. Neurosci Lett. 2011 Jan 10;487(3):378-82. doi: 10.1016/j.neulet.2010.10.060. Epub 2010 Oct 29.

    PubMed 21036201

Questions about this trial

What is this clinical trial studying?

A study testing intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS) in people with Languages, run by Jean-Marie Annoni at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 10 Apr 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching) (time frame: Within 30 minutes after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03148470, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in